Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03517228 · ClinicalTrials.gov registry record · NA

Pilot Trial of the Robotic Uterine Manipulator

A NA study, sponsored by Memorial Sloan Kettering Cancer Center.

Terminated
Registry status
NA
Development phase
28
Enrollment target

NCT03517228: Clinical Trial NA study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT03517228 is a NA study that was terminated before completion, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03517228, a NA study, was terminated before completion, sponsored by Memorial Sloan Kettering Cancer Center.

TERMINATED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

The purpose of this study is to test a robotic uterine manipulator system called the Barakat Automated Uterine Manipulator (BAUM), which will assist the surgeon in moving and positioning the uterus during a hysterectomy. This new device will allow the surgeon to control the movements of the robotic arm directly instead of giving verbal instructions to a staff member. The BAUM has never been used during surgeries before this trial. Overall, the study goal is to determine whether the use of this robotic uterine manipulator system can be safely used in the operating room while improving surgeon control during the procedure.

Interventions

  • DEVICE BAUM device

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2018-04-24
Est. Completion 2023-12-12
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT03517228

The ClinicalTrials.gov registry entry for NCT03517228 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which BAUM device is the first listed.

NCT03517228 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03517228 about?

NCT03517228 is a clinical study titled "Pilot Trial of the Robotic Uterine Manipulator". The purpose of this study is to test a robotic uterine manipulator system called the Barakat Automated Uterine Manipulator (BAUM), which will assist the surgeon in moving and positioning the uterus during a hysterectomy. This new device will allow the surgeon to control the movements of the robotic ...

What is the current status of trial NCT03517228?

This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2018-04-24. Estimated completion is 2023-12-12.

What interventions are being tested in trial NCT03517228?

The interventions under investigation include: BAUM device (DEVICE).

Who is sponsoring clinical trial NCT03517228?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.